Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CalciMedica ( (CALC) ) has shared an update.
On March 13, 2026, CalciMedica, Inc. received notice from Nasdaq that it was not in compliance with Listing Rule 5550(b)(2) because its market value of listed securities had been below the $35 million minimum for 30 consecutive business days, and it also failed to meet alternative equity and net income standards. The company has until September 9, 2026, to regain compliance by meeting any of the applicable market value, stockholders’ equity, or net income thresholds, or it faces the prospect of its securities being delisted from the Nasdaq Capital Market.
On March 16, 2026, CalciMedica was separately notified that it was out of compliance with Nasdaq’s minimum bid price requirement after its stock traded below $1.00 for 30 consecutive business days. The company has until September 14, 2026, to lift its share price to at least $1.00 for 10 straight business days, may qualify for an additional 180-day cure period under certain conditions, and is considering options such as a reverse stock split, although the Nasdaq notices do not immediately affect trading.
The most recent analyst rating on (CALC) stock is a Hold with a $0.79 price target. To see the full list of analyst forecasts on CalciMedica stock, see the CALC Stock Forecast page.
Spark’s Take on CALC Stock
According to Spark, TipRanks’ AI Analyst, CALC is a Neutral.
The score is primarily weighed down by weak financials (no revenue, continued losses, substantial cash burn, and negative equity) and bearish technical trend signals (below major moving averages with negative MACD). Valuation offers limited support due to negative earnings and no dividend, and corporate events add risk given the halted Phase 2 trial despite a modest runway extension.
To see Spark’s full report on CALC stock, click here.
More about CalciMedica
CalciMedica, Inc. is a publicly traded company listed on the Nasdaq Capital Market under the ticker symbol CALC. The company’s common stock is subject to Nasdaq’s continued listing standards, including minimum thresholds for market value, stockholders’ equity, net income from continuing operations, and minimum bid price per share.
Average Trading Volume: 1,267,650
Technical Sentiment Signal: Sell
Current Market Cap: $13.12M
See more data about CALC stock on TipRanks’ Stock Analysis page.